{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:56:58Z","timestamp":1789660618381,"version":"4.0.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018949","name":"Oulu University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016332","name":"Medical Research Center Oulu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["294738"],"award-info":[{"award-number":["294738"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jid.2022.07.006","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T18:42:58Z","timestamp":1659292978000},"page":"78-86.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Dipeptidyl Peptidase 4 Inhibitor\u2012Associated Bullous Pemphigoid Is Characterized by an Altered Expression of Cytokines in the Skin"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7200-6442","authenticated-orcid":false,"given":"Jussi","family":"Tuusa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0913-4892","authenticated-orcid":false,"given":"Nina","family":"Kokkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Mattila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7597-4323","authenticated-orcid":false,"given":"Laura","family":"Huilaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-2611","authenticated-orcid":false,"given":"Outi","family":"Varpuluoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4018-8752","authenticated-orcid":false,"given":"Sirpa","family":"Rannikko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3461-6471","authenticated-orcid":false,"given":"Virpi","family":"Glumoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0575-2669","authenticated-orcid":false,"given":"Jouko","family":"Miettunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8056-5949","authenticated-orcid":false,"given":"Kaisa","family":"Tasanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2022.07.006_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","article-title":"Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management","volume":"54","author":"Amber","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2133.2006.07305.x","article-title":"Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris","volume":"155","author":"Asashima","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2017.03.010","article-title":"Bullous pemphigoid","volume":"16","author":"Ba\u011fci","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2022.07.006_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s00403-021-02249-4","article-title":"Inhibition of dipeptidyl-peptidase 4 induces upregulation of the late cornified envelope cluster in keratinocytes [e-pub ahead of print]","author":"Bao","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2022.07.006_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: a prospective case-control study","volume":"131","author":"Bastuji-Garin","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib6","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.4049\/jimmunol.170.9.4810","article-title":"CC chemokine ligand 1 promotes recruitment of eosinophils but not Th2 cells during the development of allergic airways disease","volume":"170","author":"Bishop","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.12.034","article-title":"Control of chemokine-guided cell migration by ligand sequestration","volume":"132","author":"Boldajipour","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jid.2022.07.006_bib8","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1136\/ard.2011.150219","article-title":"A\u00a0BAFF\/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells","volume":"70","author":"Bombardieri","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2022.07.006_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3325\/cmj.2020.61.93","article-title":"The association between clinical and laboratory findings of bullous pemphigoid and dipeptidyl peptidase-4 inhibitors in the elderly: a retrospective study","volume":"61","author":"Bukvi\u0107 Mokos","year":"2020","journal-title":"Croat Med J"},{"key":"10.1016\/j.jid.2022.07.006_bib10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/1346-8138.14245","article-title":"Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid","volume":"45","author":"Chijiwa","year":"2018","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s004030050272","article-title":"IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severity","volume":"290","author":"D\u2019Auria","year":"1998","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2022.07.006_bib12","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.4049\/jimmunol.144.11.4092","article-title":"Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways","volume":"144","author":"Dang","year":"1990","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1067\/mai.2002.127003","article-title":"High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome","volume":"110","author":"de Lavareille","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib14","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/dc19-0409","article-title":"Dipeptidyl peptidase 4 inhibitors and the risk of bullous pemphigoid among patients with Type 2 diabetes","volume":"42","author":"Douros","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jid.2022.07.006_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pharmthera.2019.02.005","article-title":"What doesn\u2019t kill you makes you stranger: dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands","volume":"198","author":"Elmansi","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jid.2022.07.006_bib16","first-page":"833","article-title":"S2k guidelines for the treatment of pemphigus vulgaris\/foliaceus and bullous pemphigoid","volume":"13","author":"Eming","year":"2015","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.jid.2022.07.006_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017739","article-title":"IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation","volume":"6","author":"Eto","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2022.07.006_bib18","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.3390\/cells9122627","article-title":"Skin-associated B cells in the pathogenesis of cutaneous autoimmune diseases-implications for therapeutic approaches","volume":"9","author":"Fetter","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jid.2022.07.006_bib19","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4049\/jimmunol.181.2.1120","article-title":"Inhibition of CD26\/dipeptidyl peptidase IV enhances CCL11\/eotaxin-mediated recruitment of eosinophils in\u00a0vivo","volume":"181","author":"Forssmann","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib20","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/exd.13401","article-title":"Neurological and psychiatric associations in bullous pemphigoid-more than skin deep?","volume":"26","author":"F\u00f6rsti","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib21","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/bjd.13189","article-title":"Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital","volume":"171","author":"F\u00f6rsti","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib22","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4049\/jimmunol.133.3.1250","article-title":"Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody","volume":"133","author":"Fox","year":"1984","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib23","first-page":"97","article-title":"Pathogenesis of atopic dermatitis: current paradigm","volume":"16","author":"Furue","year":"2019","journal-title":"Iran J Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.imbio.2016.09.007","article-title":"Dipeptidyl peptidase 9 (DPP9) in human skin cells","volume":"222","author":"Gabrilovac","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.jid.2022.07.006_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jcb.20041","article-title":"Amino-terminal processing of MIP-1beta\/CCL4 by CD26\/dipeptidyl-peptidase IV","volume":"92","author":"Guan","year":"2004","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.jid.2022.07.006_bib26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jid.2019.11.005","article-title":"Recent advances in understanding pemphigus and bullous pemphigoid","volume":"140","author":"Hammers","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/imm.12028","article-title":"CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production","volume":"138","author":"Hatano","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.jid.2022.07.006_bib28","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3389\/fimmu.2019.01454","article-title":"Proteases in pemphigoid diseases","volume":"10","author":"Hiroyasu","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib29","doi-asserted-by":"crossref","first-page":"12138","DOI":"10.1073\/pnas.211439098","article-title":"CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO","volume":"98","author":"Ishii","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2022.07.006_bib30","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bcp.2017.03.009","article-title":"Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes","volume":"132","author":"Janssens","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jid.2022.07.006_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s004030100230","article-title":"Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis","volume":"293","author":"Kaburagi","year":"2001","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2022.07.006_bib33","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/bjd.19808","article-title":"Inducible skin-associated lymphoid tissue (iSALT) in a patient with Schnitzler syndrome who manifested wheals on recurrent localized erythema","volume":"184","author":"Kamido","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib34","first-page":"1916","article-title":"Clinical, Laboratory and histological features of dipeptidyl peptidase-4 inhibitor related noninflammatory bullous pemphigoid","volume":"10","author":"Kiny\u00f3","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jid.2022.07.006_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733484","article-title":"Putative immunological functions of inducible skin-associated lymphoid tissue in the context of mucosa-associated lymphoid tissue","volume":"12","author":"Kogame","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib36","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/intimm\/dxp102","article-title":"IL-5- and eosinophil-mediated inflammation: from discovery to therapy","volume":"21","author":"Kouro","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib37","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.autrev.2019.03.009","article-title":"Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid","volume":"18","author":"Kowalski","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2022.07.006_bib38","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jamadermatol.2018.2352","article-title":"Association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors in patients with diabetes: estimating the risk of the new agents and characterizing the patients","volume":"154","author":"Kridin","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib39","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.162.8.4455","article-title":"Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells","volume":"162","author":"Krzysiek","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib40","doi-asserted-by":"crossref","first-page":"29839","DOI":"10.1074\/jbc.M103106200","article-title":"Kinetic investigation of chemokine truncation by CD26\/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family","volume":"276","author":"Lambeir","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2022.07.006_bib41","article-title":"Follicular helper T cells (Tfh) and IL-21 involvement in the pathogenesis of bullous pemphigoid","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2022.07.006_bib42","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2340\/00015555-3166","article-title":"Gliptin-associated bullous pemphigoid and the expression of dipeptidyl peptidase-4\/CD26 in bullous pemphigoid","volume":"99","author":"Lindgren","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2022.07.006_bib43","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jid.2017.03.019","article-title":"TWEAK\/Fn14 activation contributes to the pathogenesis of bullous pemphigoid","volume":"137","author":"Liu","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1208\/s12248-010-9208-y","article-title":"Peptidomics of the prolyl peptidases","volume":"12","author":"Lone","year":"2010","journal-title":"AAPS J"},{"key":"10.1016\/j.jid.2022.07.006_bib45","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.ajpath.2017.04.017","article-title":"Elevated CD26 expression by skin fibroblasts distinguishes a profibrotic phenotype involved in scar formation compared to gingival fibroblasts","volume":"187","author":"Mah","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2022.07.006_bib46","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3389\/fimmu.2019.01224","article-title":"Preferential reactivity of dipeptidyl peptidase-IV inhibitor-associated bullous pemphigoid autoantibodies to the processed extracellular domains of BP180","volume":"10","author":"Mai","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib47","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/exd.14209","article-title":"Distinct compartmentalization of immune cells and mediators characterizes bullous pemphigoid disease","volume":"29","author":"Margaroli","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib48","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3390\/ijms18071513","article-title":"Glycosaminoglycans regulate CXCR3 ligands at distinct levels: protection against processing by dipeptidyl peptidase IV\/CD26 and interference with receptor signaling","volume":"18","author":"Metzemaekers","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2022.07.006_bib49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jdermsci.2008.10.012","article-title":"Increased CCL1 levels in the sera and blister fluid of patients with bullous pemphigoid","volume":"54","author":"Miyagaki","year":"2009","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2022.07.006_bib50","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3390\/biom10101432","article-title":"Bullous pemphigoid: trigger and predisposing factors","volume":"10","author":"Moro","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jid.2022.07.006_bib51","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1210\/er.2014-1035","article-title":"Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors","volume":"35","author":"Mulvihill","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jid.2022.07.006_bib52","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.4049\/jimmunol.164.11.5935","article-title":"Expression of CXCR4 in eosinophils: functional analyses and cytokine-mediated regulation","volume":"164","author":"Nagase","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib53","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/exd.14387","article-title":"Defining dipeptidyl peptidase-4 inhibitors-related bullous pemphigoid: a single-centre retrospective study","volume":"30","author":"Nieto-Benito","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jdermsci.2013.12.001","article-title":"Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII","volume":"73","author":"Nishie","year":"2014","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2022.07.006_bib55","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jid.2018.11.025","article-title":"Gliptin-associated bullous pemphigoid: A valuable model of the mechanism of breakdown of immune tolerance against BP180","volume":"139","author":"Nishie","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib56","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2008.02.010","article-title":"Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function","volume":"29","author":"Ohnuma","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib57","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/exd.14228","article-title":"The role of dipeptidyl peptidase-4 in cutaneous disease","volume":"30","author":"Patel","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib58","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1684\/ejd.2018.3371","article-title":"Bullous pemphigoid in patients with DPP-4 inhibitors at the onset of disease: does this differ from common bullous pemphigoid?","volume":"28","author":"Patsatsi","year":"2018","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejps.2016.12.040","article-title":"Sitagliptin inhibit human lymphocytes proliferation and Th1\/Th17 differentiation in\u00a0vitro","volume":"100","author":"Pinheiro","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jid.2022.07.006_bib60","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jid.2018.10.045","article-title":"Higher frequency of dipeptidyl peptidase-4 inhibitor intake in bullous pemphigoid patients than in the French general population","volume":"139","author":"Plaquevent","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib61","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1074\/jbc.273.13.7222","article-title":"Amino-terminal truncation of chemokines by CD26\/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection","volume":"273","author":"Proost","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2022.07.006_bib62","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/exd.12421","article-title":"B-cell activating factor detected on both na\u00efve and memory B cells in bullous pemphigoid","volume":"23","author":"Qian","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib63","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1038\/s41598-018-28070-0","article-title":"Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction","volume":"8","author":"Russo","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2022.07.006_bib64","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaad.2022.02.036","article-title":"Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: results of a multicenter study","volume":"87","author":"Salemme","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib65","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1523-1747.2000.00141.x","article-title":"Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes","volume":"115","author":"Schmidt","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib66","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2022.07.006_bib67","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40257-020-00563-7","article-title":"More severe erosive phenotype despite lower circulating autoantibody levels in dipeptidyl peptidase-4 inhibitor (DPP4i)-associated bullous pemphigoid: a retrospective cohort study","volume":"22","author":"St\u00e4nder","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib68","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10555-010-9256-x","article-title":"CXCL12 \/ CXCR4 \/ CXCR7 chemokine axis and cancer progression [published correction appears in cancer Metastasis Rev 2011;30:269\u201270]","volume":"29","author":"Sun","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jid.2022.07.006_bib69","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1111\/jdv.16851","article-title":"Serum thymus and activation-regulated chemokine (TARC\/CCL17) may be useful to predict the disease activity in patients with bullous pemphigoid","volume":"35","author":"Suzuki","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2022.07.006_bib70","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3389\/fimmu.2019.01238","article-title":"Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid","volume":"10","author":"Tasanen","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212233","article-title":"BP180\/collagen XVII: A molecular view","volume":"22","author":"Tuusa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2022.07.006_bib72","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0091-6749(97)70248-3","article-title":"Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets","volume":"100","author":"Willheim","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108546","article-title":"Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: a population-based cohort study","volume":"171","author":"Wu","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jid.2022.07.006_bib74","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2133.2006.07305.x","article-title":"Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris","volume":"155","author":"Asashima","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib75","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2018.09.003","article-title":"IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid","volume":"96","author":"Chakievska","year":"2019","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2022.07.006_bib76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s004030050272","article-title":"IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severity","volume":"290","author":"D\u2019Auria","year":"1998","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2022.07.006_bib77","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF00372588","article-title":"Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid","volume":"284","author":"Endo","year":"1992","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2022.07.006_bib78","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/cyto.2000.0791","article-title":"Bullous pemphigoid: interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation","volume":"13","author":"Engineer","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.jid.2022.07.006_bib79","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2133.2008.08979.x","article-title":"CCL18 is expressed in patients with bullous pemphigoid and parallels disease course","volume":"160","author":"G\u00fcnther","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib80","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2249.2011.04464.x","article-title":"Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid","volume":"166","author":"G\u00fcnther","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib81","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0923-1811(97)00044-3","article-title":"Increased serum levels of interleukin (IL)-5, IL-6 and IL-8 in bullous pemphigoid","volume":"16","author":"Inaoki","year":"1998","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2022.07.006_bib82","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.autrev.2019.03.009","article-title":"Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid","volume":"18","author":"Kowalski","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2022.07.006_bib83","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3389\/fimmu.2019.01972","article-title":"IL-23\/IL-17 axis activates IL-1\u03b2-associated inflammasome in macrophages and generates an auto-inflammatory response in a subgroup of patients with bullous pemphigoid","volume":"10","author":"Le Jan","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2022.07.006_bib84","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1038\/jid.2014.263","article-title":"Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid","volume":"134","author":"Le Jan","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib85","article-title":"Follicular helper T cells (Tfh) and IL-21 involvement in the pathogenesis of bullous pemphigoid","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2022.07.006_bib86","article-title":"Thymic stromal lymphopoietin is implicated in the pathogenesis of bullous pemphigoid by dendritic cells","volume":"2020","author":"Li","year":"2020","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.jid.2022.07.006_bib87","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jid.2017.03.019","article-title":"TWEAK\/Fn14 activation contributes to the pathogenesis of bullous pemphigoid","volume":"137","author":"Liu","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib88","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jdermsci.2008.10.012","article-title":"Increased CCL1 levels in the sera and blister fluid of patients with bullous pemphigoid","volume":"54","author":"Miyagaki","year":"2009","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2022.07.006_bib89","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2133.2006.07601.x","article-title":"Serum chemokine profile in patients with bullous pemphigoid","volume":"156","author":"Nakashima","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib90","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/jdv.12719","article-title":"Serum thymus and activation-regulated chemokine (TARC\/CCL17) levels reflect the disease activity in a patient with bullous pemphigoid","volume":"30","author":"Nin-Asai","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2022.07.006_bib91","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/exd.12421","article-title":"B-cell activating factor detected on both na\u00efve and memory B cells in bullous pemphigoid","volume":"23","author":"Qian","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib92","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1523-1747.2000.00141.x","article-title":"Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes","volume":"115","author":"Schmidt","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib93","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/000155500750012162","article-title":"Increased coexpression of eotaxin and interleukin 5 in bullous pemphigoid","volume":"80","author":"Shrikhande","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2022.07.006_bib94","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1111\/jdv.16851","article-title":"Serum thymus and activation-regulated chemokine (TARC\/CCL17) may be useful to predict the disease activity in patients with bullous pemphigoid","volume":"35","author":"Suzuki","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2022.07.006_bib95","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1365-2133.2000.03599.x","article-title":"Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia","volume":"143","author":"Wakugawa","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.07.006_bib96","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jdermsci.2006.12.008","article-title":"Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid","volume":"46","author":"Watanabe","year":"2007","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2022.07.006_bib97","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8980534","article-title":"Correlation between IL36\u03b1 and IL17 and activity of the disease in selected autoimmune blistering diseases","volume":"2017","author":"\u017bebrowska","year":"2017","journal-title":"Mediators Inflammm"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X22016815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X22016815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:51:01Z","timestamp":1762206661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X22016815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0022202X22016815"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2022.07.006","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dipeptidyl Peptidase 4 Inhibitor\u2012Associated Bullous Pemphigoid Is Characterized by an Altered Expression of Cytokines in the Skin","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2022.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}